Jim Cramer Explains Why Merck (MRK) Is His Fantasy Defense Stock

insidermonkey.com · 2026-09-12

Discussing his fantasy roster on the September 8 episode of Mad Money, Jim Cramer turned his focus to pharmaceutical giant Merck & Co., Inc.

TickrTrends take: Jim Cramer has identified Merck as a defensive stock pick, suggesting it may appeal to investors seeking stability during market uncertainty. Given that TickrTrends currently rates MRK as overvalued within the Healthcare sector, investors focused on valuation metrics should monitor whether the stock's defensive characteristics justify its current price level or whether a pullback might offer better entry opportunities. The tension between MRK's perceived defensive value and its current overvalued status represents a key consideration for value-conscious investors evaluating the stock.

Read the full story at insidermonkey.com →